Both in Surgical Instruments
Carlsmed vs Neuropace
Over the past year CARL returned +17.8% and NPCE returned +31.0%; their daily moves had a correlation of 0.28.
CARL +17.8% NPCE +31.0%Growth of $1, one year, split-adjusted
| Metric | CARL | NPCE |
|---|---|---|
| Price | $14.40 | $12.31 |
| Market cap | $393.2M | $422.5M |
| Today | −4.13% | −0.24% |
| 1 month | −5.9% | −6.9% |
| 6 months | +61.4% | −27.8% |
| Year to date | +16.6% | −20.3% |
| 1 year | +11.7% | +23.8% |
| Revenue growth (YoY) | — | +17.1% |
| Gross margin | 76.8% | 82.8% |
| Net margin | −55.5% | −27.2% |
| P/E (TTM) | — | — |
| Price / sales | 6.2× | 4.3× |
| Net cash | $73.8M | -$7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 47.7% | 40.2% |
| Short % of float | 11.3% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).